The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer

Koki Goto,Ryusei Matsuyama,Yusuke Suwa,Sayaka Arisaka,Toshiaki Kadokura,Mari Sato,Ryutaro Mori,Takafumi Kumamoto,Masataka Taguri,Itaru Endo

The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer

2018

Koki Goto
Ryusei Matsuyama
Yusuke Suwa
Sayaka Arisaka
Toshiaki Kadokura
Mari Sato
Ryutaro Mori
Takafumi Kumamoto
Masataka Taguri
Itaru Endo

Purpose To assess the predictive ability of the maximum chemiluminescence intensity (CImax) for severe neutropenia (SN) during neoadjuvant chemo(radio)therapy [NAC(RT)] in patients with advanced pancreatic or biliary tract cancer.

Keywords:

Neutropenia
Pancreatic cancer
Cancer
Biliary tract
Pharmacology
Gemcitabine
General surgery
Medicine
Chemiluminescence
Tegafur
Blood test
Gastroenterology
Internal medicine
Titer
Absolute neutrophil count

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations